Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLISSET study of 0.005% estriol vaginal gel in postmenopausal women with vaginal atrophy
2019-001435-31Phase 4Active
- Sponsor
- ITF Research Pharma
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of estriol in vaginal atrophy, sponsored by ITF Research Pharma. Primary endpoint: Change in vaginal epithelium maturation value at 2 weeks. Started Jun 2019; status: active.
02
Drugs
estriol
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on 2019-001435-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001435-31.